$BRTX
BioRestorative Therapies, Inc.

2011 Q4 Form 10-K Financial Statement

#000114420412021914 Filed on April 16, 2012

View on sec.gov

Income Statement

Concept 2011 Q4 2011 2010 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.540M
YoY Change 71.84%
% of Gross Profit
Research & Development $12.00K
YoY Change 3.27%
% of Gross Profit
Depreciation & Amortization $90.41K
YoY Change 86.96%
% of Gross Profit
Operating Expenses $3.552M
YoY Change 71.65%
Operating Profit -$3.552M
YoY Change 71.65%
Interest Expense $260.0K
YoY Change 976.43%
% of Operating Profit
Other Income/Expense, Net -$521.9K
YoY Change 168.4%
Pretax Income -$4.070M
YoY Change 80.09%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.074M
YoY Change 79.96%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$7.268M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2011 Q4 2011 2010 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00K
YoY Change 250.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $50.00K
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $118.4K $120.0K $18.07K
YoY Change 555.21% 500.0%
LONG-TERM ASSETS
Property, Plant & Equipment $94.83K $90.00K $446.8K
YoY Change -78.77% -80.0%
Goodwill
YoY Change
Intangibles $3.308K $3.676K
YoY Change -10.01%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $102.6K $100.0K $450.4K
YoY Change -77.23% -77.78%
TOTAL ASSETS
Total Short-Term Assets $118.4K $120.0K $18.07K
Total Long-Term Assets $102.6K $100.0K $450.4K
Total Assets $221.0K $220.0K $468.5K
YoY Change -52.83% -53.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $426.2K $430.0K $160.2K
YoY Change 166.05% 168.75%
Accrued Expenses $440.2K $440.0K $341.6K
YoY Change 28.87% 29.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $3.040M
YoY Change 496.08%
Total Short-Term Liabilities $3.907M $3.910M $1.016M
YoY Change 284.64% 283.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $196.9K
YoY Change -100.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $196.9K
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.907M $3.910M $1.016M
Total Long-Term Liabilities $0.00 $196.9K
Total Liabilities $3.907M $3.910M $1.213M
YoY Change 222.2% 223.14%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $635.6K $461.1K
YoY Change 37.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $32.00K $32.00K
YoY Change 0.0%
Treasury Stock Shares 27.93M shares 27.93M shares
Shareholders Equity -$3.686M -$3.690M -$744.2K
YoY Change
Total Liabilities & Shareholders Equity $221.0K $220.0K $468.5K
YoY Change -52.83% -53.19%

Cashflow Statement

Concept 2011 Q4 2011 2010 Q4
OPERATING ACTIVITIES
Net Income -$4.074M
YoY Change 79.96%
Depreciation, Depletion And Amortization $90.41K
YoY Change 86.96%
Cash From Operating Activities -$2.811M
YoY Change 285.46%
INVESTING ACTIVITIES
Capital Expenditures $17.77K
YoY Change -60.84%
Acquisitions
YoY Change
Other Investing Activities $30.00K
YoY Change
Cash From Investing Activities $14.23K
YoY Change -129.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000K
YoY Change -85.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.850M
YoY Change 258.03%
NET CHANGE
Cash From Operating Activities -2.811M
Cash From Investing Activities 14.23K
Cash From Financing Activities 2.850M
Net Change In Cash 53.43K
YoY Change 196.33%
FREE CASH FLOW
Cash From Operating Activities -$2.811M
Capital Expenditures $17.77K
Free Cash Flow -$2.829M
YoY Change 265.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
647991911 shares
CY2011Q2 dei Entity Public Float
EntityPublicFloat
9563385
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-51087
CY2009Q4 us-gaap Cash
Cash
42
CY2009Q4 brtx Warrant Issue Date
WarrantIssueDate
2009-08-06
CY2010Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
19476
CY2010Q4 us-gaap Treasury Stock Value
TreasuryStockValue
32000
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1015852
CY2010Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
196876
CY2010Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
341618
CY2010Q4 us-gaap Assets
Assets
468506
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
461149
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
433217500 shares
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2010Q4 us-gaap Assets Current
AssetsCurrent
18074
CY2010Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
3450561
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2270219
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
468506
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-744222
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
461148534 shares
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
446756
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2010Q4 us-gaap Liabilities
Liabilities
1212728
CY2010Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27931034 shares
CY2010Q4 us-gaap Notes Payable Current
NotesPayableCurrent
514047
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
160187
CY2010Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3676
CY2010Q4 us-gaap Cash
Cash
18074
CY2010Q4 brtx Common Stock Repurchased Date
CommonStockRepurchasedDate
2010-02-16
CY2010Q4 brtx Common Stock Issuable Shares Value
CommonStockIssuableSharesValue
6971
CY2011Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
149043
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
32000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3907370
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
440229
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46915
CY2011Q4 us-gaap Assets
Assets
220973
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
635615
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
607683811 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
118423
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
7524498
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3234486
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220973
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-3686397
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
635614845 shares
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94827
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2011Q4 us-gaap Liabilities
Liabilities
3907370
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27931034 shares
CY2011Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3040957
CY2011Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4415
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
426184
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3308
CY2011Q4 us-gaap Cash
Cash
71508
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
32000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
552729
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-134919
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
291055
us-gaap Revenues
Revenues
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1875
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3743165
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
556096
us-gaap Professional Fees
ProfessionalFees
2220608
us-gaap Share Based Compensation
ShareBasedCompensation
2282151
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21614
us-gaap Interest Expense
InterestExpense
288498
us-gaap Net Income Loss
NetIncomeLoss
-7534862
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3573639
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-749689
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23620
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
307818
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145182
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
163243
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
83448
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3791697
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3676
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2141038
us-gaap Operating Income Loss
OperatingIncomeLoss
-6785173
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
368703
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11457
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
46915
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
26000
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
71508
us-gaap Interest Paid
InterestPaid
202997
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
4415
us-gaap Operating Expenses
OperatingExpenses
6785173
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2092089
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3949592
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
485222
brtx Amounts Payable Related To Common Stock Repurchased
AmountsPayableRelatedToCommonStockRepurchased
7000
brtx Contingent Common Stock Issued
ContingentCommonStockIssued
12577
brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
891300
brtx Property Plant And Equipment Additions In Accounts Payable
PropertyPlantAndEquipmentAdditionsInAccountsPayable
60000
brtx Supplemental Reduction Of Fixed Assets Based On Write Off Of Capital Lease
SupplementalReductionOfFixedAssetsBasedOnWriteOffOfCapitalLease
226043
CY2008Q4 us-gaap Net Income Loss
NetIncomeLoss
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-1197126
CY2009 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
52379
CY2009 brtx Warrants Price Per Share
WarrantsPricePerShare
0.01
CY2009 brtx Common Stock Cancelled Price Per Share
CommonStockCancelledPricePerShare
0.001
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583685
CY2010 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28000
CY2010 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
321008
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48784
CY2010 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
291055
CY2010 us-gaap Revenues
Revenues
CY2010 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1875
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-729218
CY2010 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
181739
CY2010 us-gaap Professional Fees
ProfessionalFees
682152
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
895608
CY2010 us-gaap Interest Expense
InterestExpense
24155
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-2263799
CY2010 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
332654
CY2010 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-194462
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11620
CY2010 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
124850
CY2010 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48358
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45383
CY2010 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1534581
CY2010 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3401
CY2010 us-gaap Labor And Related Expense
LaborAndRelatedExpense
760171
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-2069337
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
81918
CY2010 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11432
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5950
CY2010 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
18032
CY2010 us-gaap Interest Paid
InterestPaid
16847
CY2010 us-gaap Operating Expenses
OperatingExpenses
2069337
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
490544
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
796034
CY2010 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
176795
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2010 brtx Amounts Payable Related To Common Stock Repurchased
AmountsPayableRelatedToCommonStockRepurchased
7000
CY2010 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
666300
CY2010 brtx Property Plant And Equipment Additions In Accounts Payable
PropertyPlantAndEquipmentAdditionsInAccountsPayable
60000
CY2010 brtx Supplemental Noncash Transations
SupplementalNoncashTransations
-6971
CY2010 brtx Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
470404418 shares
CY2010 brtx Stock Repurchased And Retired During Period Average Price
StockRepurchasedAndRetiredDuringPeriodAveragePrice
0.001
CY2010 brtx Common Stock Repurchase Price Per Share
CommonStockRepurchasePricePerShare
0.027
CY2010 brtx Equity Repurchase And Retired Date
EquityRepurchaseAndRetiredDate
2010-10-13
CY2010 brtx Shares Returned Issued As Collateral In Connection With Note Payable
SharesReturnedIssuedAsCollateralInConnectionWithNotePayable
-530000
CY2011 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2011 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2011 dei Trading Symbol
TradingSymbol
BRTX
CY2011 dei Entity Registrant Name
EntityRegistrantName
BIORESTORATIVE THERAPIES, INC.
CY2011 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 dei Amendment Flag
AmendmentFlag
false
CY2011 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2011 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
CY2011 dei Document Type
DocumentType
10-K
CY2011 dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
CY2011 dei Entity Central Index Key
EntityCentralIndexKey
0001505497
CY2011 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50932
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000
CY2011 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26000
CY2011 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
215111
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14228
CY2011 us-gaap Revenues
Revenues
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2810867
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
345369
CY2011 us-gaap Professional Fees
ProfessionalFees
682171
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
456826
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21614
CY2011 us-gaap Interest Expense
InterestExpense
260011
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-4073937
CY2011 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2962500
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-521932
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12000
CY2011 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
103696
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
90412
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17772
CY2011 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
83448
CY2011 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1263070
CY2011 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1380867
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-3552005
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
268516
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
46915
CY2011 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
26000
CY2011 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
53434
CY2011 us-gaap Interest Paid
InterestPaid
186150
CY2011 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
4415
CY2011 us-gaap Operating Expenses
OperatingExpenses
3552005
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1373271
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2850073
CY2011 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
308427
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011 brtx Contingent Common Stock Issued
ContingentCommonStockIssued
12577
CY2011 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
200000
CY2011 brtx Supplemental Noncash Transations
SupplementalNoncashTransations
6971
CY2011 brtx Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
561287751 shares
CY2011 brtx Supplemental Reduction Of Fixed Assets Based On Write Off Of Capital Lease
SupplementalReductionOfFixedAssetsBasedOnWriteOffOfCapitalLease
226043

Files In Submission

Name View Source Status
0001144204-12-021914-index-headers.html Edgar Link pending
0001144204-12-021914-index.html Edgar Link pending
0001144204-12-021914.txt Edgar Link pending
0001144204-12-021914-xbrl.zip Edgar Link pending
brtx-20111231.xml Edgar Link completed
brtx-20111231.xsd Edgar Link pending
brtx-20111231_cal.xml Edgar Link unprocessable
brtx-20111231_def.xml Edgar Link unprocessable
brtx-20111231_lab.xml Edgar Link unprocessable
brtx-20111231_pre.xml Edgar Link unprocessable
ex3-1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v308966_10k.htm Edgar Link pending
v308966_ex10-13.htm Edgar Link pending
v308966_ex10-17.htm Edgar Link pending
v308966_ex10-27.htm Edgar Link pending
v308966_ex10-4.htm Edgar Link pending
v308966_ex10-44.htm Edgar Link pending
v308966_ex10-45.htm Edgar Link pending
v308966_ex10-46.htm Edgar Link pending
v308966_ex10-47.htm Edgar Link pending
v308966_ex10-48.htm Edgar Link pending
v308966_ex10-49.htm Edgar Link pending
v308966_ex10-50.htm Edgar Link pending
v308966_ex10-51.htm Edgar Link pending
v308966_ex10-52.htm Edgar Link pending
v308966_ex14.htm Edgar Link pending
v308966_ex3-1.htm Edgar Link pending
v308966_ex3-2.htm Edgar Link pending
v308966_ex31-1.htm Edgar Link pending
v308966_ex31-2.htm Edgar Link pending
v308966_ex32.htm Edgar Link pending